Evidence Hub

Comparative evaluation of the clinical and radiographic efficacy of 0.05% Zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus - A randomized split-mouth clinical trial

S. Raj, A. Mishra, Devapratim Mohanty, Neelima Katti, S. Pattnaik, Laxmikanta Patra, Abinash Pattanaik

Clinical Advances in Periodontics, 2023

7 citations

Abstract

BACKGROUND

This 6-month randomized split-mouth and placebo-controlled clinical trial aimed to evaluate the clinical and radiographic efficacy of adjunctive use of 0.05% ZLN gel as local drug delivery (LDD) to scaling and root planning (SRP) in stage III, grade B periodontitis patients with and without controlled type-2 diabetes mellitus (DM).

METHODS

120 infrabony sites were divided into two groups; GROUP-1 (non-diabetic periodontitis) and GROUP-2 (periodontitis +DM). 60 sites in each group were randomized to receive treatment with SRP+placebo gel (control) or SRP+0.05% ZLN gel (test). Plaque index (PI), modified sulcus bleeding index (mSBI), pocket probing depth (PPD) and relative attachment levels (RAL) were assessed at baseline, 3 and 6-months and digital periapical (IOPA) and cone-beam computed tomography (CBCT) imaging were used to measure the linear and percentage reduction of intrabony defect depth (DD, DDR%) after 6-months.

RESULTS

GROUP-1 showed significant reduction in PI (0.56±0.15 and 0.52±0.19 from 0.67±0.17), mSBI (0.7±0.60 and 0.47±0.57 from 0.9±0.48), PPD (4.6±0.85 and 3.43±0.63 from 6.5±1.04) and gain in RAL (7.03±0.85 and 5.93±0.69 from 8.9±1.09) in the ZLN treated sites than the placebo sites and also from GROUP-2 sites after 3 and 6 months respectively. A significant reduction in defect depth of 28.79% in GROUP-1 and 22.20% in GROUP-2 at ZLN sites was seen compared to placebo sites of both groups.

CONCLUSION

ZLN gel applied subgingivally in infrabony…

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free